<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Can J Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Can. J. Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">133</journal-id><journal-id journal-id-type="pmc-domain">cjvetres</journal-id><journal-title-group><journal-title>Canadian Journal of Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0830-9000</issn><issn pub-type="epub">1928-9022</issn><publisher><publisher-name>Canadian Veterinary Medical Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6753886</article-id><article-id pub-id-type="pmcid-ver">PMC6753886.1</article-id><article-id pub-id-type="pmcaid">6753886</article-id><article-id pub-id-type="pmcaiid">6753886</article-id><article-id pub-id-type="pmid">31571725</article-id><article-id pub-id-type="publisher-id">cjvr_04_261</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Protective efficacy of a <italic toggle="yes">Brucella</italic> vaccine using a <italic toggle="yes">Salmonella</italic>-based delivery system expressing <italic toggle="yes">Brucella</italic> Omp3b, BCSP31, and SOD proteins against brucellosis in Korean black goats</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="WK">Won-Kyong</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moon</surname><given-names initials="JY">Ja-Young</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="JS">Jeong-Sang</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hur</surname><given-names initials="J">Jin</given-names></name></contrib><aff id="af1-cjvr_04_261">Veterinary Public Health, College of Veterinary Medicine, Chonbuk National University, Gobong-ro 79, Iksan, Jeollabuk-do, Republic of Korea</aff></contrib-group><author-notes><corresp id="c1-cjvr_04_261">Address all correspondence to Dr. Jin Hur; telephone: +82-63-850-0959; fax: +82-63-850-0910; e-mail: <email>hurjin@jbnu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2019</year></pub-date><volume>83</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">342490</issue-id><fpage>261</fpage><lpage>266</lpage><history><date date-type="received"><day>25</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-04-01 00:56:13.933"><day>01</day><month>04</month><year>2020</year></date></event></pub-history><permissions><copyright-statement>Copyright and/or publishing rights held by the Canadian Veterinary Medical Association</copyright-statement><copyright-year>2019</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cjvr_04_261.pdf"/><abstract><p>This study aimed to assess the protective efficacy of a novel <italic toggle="yes">Brucella</italic> vaccine formulation in goats. Twenty black goats were separated into 2 groups. Group A was injected with 3.0 &#215; 10<sup>9</sup> CFU (colony-forming units)/mL of a <italic toggle="yes">Salmonella</italic>-based delivery system harboring only vector (pMMP65). Group B was immunized with 3.0 &#215; 10<sup>9</sup> CFU/mL of the vaccine, a mixture of 3 <italic toggle="yes">Brucella</italic> vaccine strains (using a <italic toggle="yes">Salmonella</italic>-based delivery system) expressing each recombinant <italic toggle="yes">B. abortus</italic> Omp3b, BCSP31, and SOD protein. No <italic toggle="yes">Salmonella</italic> delivery strain was isolated from all tested lymph nodes and parenchymal organs. Serum immunoglobulin (Ig) G titers and interferon gamma concentrations were significantly higher in group B than those in group A. After intraconjunctival challenge with virulent <italic toggle="yes">B. abortus</italic> strain 544, 40% of the vaccinated animals in group B were protected against <italic toggle="yes">B. abortus</italic> infection. The infection index and colonization of <italic toggle="yes">B. abortus</italic> in tested tissues was significantly lower in group B than group A. We conclude that this <italic toggle="yes">Brucella</italic> vaccine induces significant antigen-specific immune responses and provides effective protection against <italic toggle="yes">B. abortus</italic> infection in goats. Further studies are needed to enhance the protection rate of this <italic toggle="yes">Brucella</italic> vaccine and to discover its practical application in small ruminants.</p></abstract><trans-abstract xml:lang="fr"><title>R&#233;sum&#233;</title><p>La pr&#233;sente &#233;tude visait &#224; &#233;valuer l&#8217;efficacit&#233; protectrice d&#8217;une nouvelle formulation de vaccin contre <italic toggle="yes">Brucella</italic> chez les ch&#232;vres. Vingt ch&#232;vres noires furent s&#233;par&#233;es en deux groupes. Le Groupe A re&#231;ut par injection 3,0 &#215; 10<sup>9</sup> unit&#233;s formatrices de colonies (UFC)/mL de <italic toggle="yes">Salmonella</italic> servant de syst&#232;me de livraison ne contenant seulement que le vecteur (pMMP65). Le groupe B fut immunis&#233; avec 3,0 &#215; 10<sup>9</sup> UFC/mL du vaccin, un m&#233;lange de trois souches vaccinales de <italic toggle="yes">Brucella</italic> (utilisant le syst&#232;me de livraison &#224; base de <italic toggle="yes">Salmonella</italic>) exprimant chaque prot&#233;ine recombinante Omp3b, BCSP31, et SOD de <italic toggle="yes">B. abortus</italic>. Aucune bact&#233;rie <italic toggle="yes">Salmonella</italic> du syst&#232;me de livraison ne fut isol&#233;e des ganglions lymphatiques et organes test&#233;s. Les concentrations s&#233;riques d&#8217;immunoglobulines G (IgG) et d&#8217;interf&#233;ron gamma &#233;taient significativement plus &#233;lev&#233;es dans le groupe B que dans le groupe A. &#192; la suite d&#8217;une infection d&#233;fi par voie intra-conjonctivale avec une souche virulente de <italic toggle="yes">B. abortus</italic> (544), 40 % des animaux vaccin&#233;s dans le groupe B &#233;taient prot&#233;g&#233;s contre l&#8217;infection par <italic toggle="yes">B. abortus</italic>. L&#8217;index d&#8217;infection et de colonisation par <italic toggle="yes">B. abortus</italic> dans les tissus test&#233;s &#233;taient significativement plus faible dans le groupe B comparativement au groupe A. Nous avons conclu que ce vaccin contre <italic toggle="yes">Brucella</italic> induisait des r&#233;ponses immunes sp&#233;cifiques d&#8217;antig&#232;ne significatives et fournissait une protection efficace contre l&#8217;infection par <italic toggle="yes">B. abortus</italic> chez les ch&#232;vres. Des &#233;tudes additionnelles sont requises afin d&#8217;augmenter le taux de protection de ce vaccin (<italic toggle="yes">Brucella</italic>) et pour d&#233;couvrir son application pratique chez les petits ruminants.</p><p>(Traduit par Docteur Serge Messier)</p></trans-abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>